- Report
- February 2026
- 369 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 278 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 466 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 244 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 569 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 179 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 372 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 245 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- January 2026
- 192 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 190 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 182 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 186 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 183 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 197 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 184 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- March 2025
- 183 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- January 2026
- 120 Pages
Global
From €4169EUR$4,750USD£3,627GBP
- Report
- May 2025
- 115 Pages
Global
From €4169EUR$4,750USD£3,627GBP
- Report
- May 2025
- 120 Pages
Global
From €4169EUR$4,750USD£3,627GBP
- Report
- May 2025
- 105 Pages
Global
From €4169EUR$4,750USD£3,627GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more